Elevated serum RAS p21 is an independent prognostic factor in metastatic breast cancer
Abstract Background An important component of the RAS signalling pathway, the RAS p21 oncogene, is frequently hyperactivated in breast cancer. Its expression in tumor tissue has been linked to poor clinical outcome. This study was designed to evaluate the clinical relevance of RAS p21 levels in peri...
Na minha lista:
| Principais autores: | , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMC
2018-05-01
|
| Serier: | BMC Cancer |
| Fag: | |
| Online adgang: | http://link.springer.com/article/10.1186/s12885-018-4282-0 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
